Effect of Methylphenidate on Sleep Parameters in Children with ADHD
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objective The primary aim of this study was to investigate the acute impact of methylphenidate (MPH) on sleep parameters in attention-deficit/hyperactivity disorder (ADHD) children. The second aim was to investigate the different effects of intermediate- and longacting MPH on sleep parameters. The third aim was to test the different effects of dose and age on sleep parameters. MethodsaaNinety-three ADHD children were enrolled and randomized to two different MPH preparations. Baseline and daily sleep diaries were evaluated for four weeks after taking medication. Weekday and weekend bedtimes, wake-up times, sleep latencies and total sleep times were compared by weeks. Results After taking MPH, there was a significant delay in bedtimes and a significant reduction of total sleep time (TST) both on weekdays and at weekends. There was also a significant delay in wake-up time on weekdays. However, the difference was applied to younger age group children only. There was no difference in changes of TST between metadate-CD and OROS-MPH. There also was no difference in changes of TST with different doses of MPH. Conclusion MPH had negative impacts on sleep among young ADHD children, but different preparations and doses did not affect the result.
Abstract
Objective The primary aim of this study was to investigate the acute impact of methylphenidate (MPH) on sleep parameters in attention-deficit/hyperactivity disorder (ADHD) children. The second aim was to investigate the different effects of intermediate- and longacting MPH on sleep parameters. The third aim was to test the different effects of dose and age on sleep parameters. MethodsaaNinety-three ADHD children were enrolled and randomized to two different MPH preparations. Baseline and daily sleep diaries were evaluated for four weeks after taking medication. Weekday and weekend bedtimes, wake-up times, sleep latencies and total sleep times were compared by weeks. Results After taking MPH, there was a significant delay in bedtimes and a significant reduction of total sleep time (TST) both on weekdays and at weekends. There was also a significant delay in wake-up time on weekdays. However, the difference was applied to younger age group children only. There was no difference in changes of TST between metadate-CD and OROS-MPH. There also was no difference in changes of TST with different doses of MPH. Conclusion MPH had negative impacts on sleep among young ADHD children, but different preparations and doses did not affect the result.
참고문헌 (26)
- American Psychi- atric Association, "Diagnostic and Statistical Manual of Mental Disorders: DSM-IV TR" (2000)
- Concannon PE., "Management of attention deficit hyperactivity disorder: a parental perspective", J Paediatr Child Health, 41, pp.625~630 (2005)
- Capp PK., "Methylphenidate HCl: therapy for attention deficit hyperactivity disorder", Expert Rev Neurother, 5, pp.325~331 (2005)
- Dulcan M., "Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit", hyperactivity disorder. American Academy of Child and Adolescent Psychiatry, 1997, pp.36, 85~121
- Kratochvil CJ., "Pharmacological management of treatment-induced insomnia in ADHD", J Am Acad Child Adolesc Psychiatry, 44, pp.499~501 (2005)
- Martins S., "Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial", J Child Adolesc Psychopharmacol, 14, pp.195~206 (2004)
- Rapport MD., "Attention-Deficit", Hyperactivity Disorder and methylphenidate: a dose-response analysis and parent-child comparison of somatic complaints, 2002, pp.6, 15~24
- Sangal RB., "Effects of atomoxetine and methylphenidate on sleep in children with ADHD", Sleep, 29, pp.1573~1585 (2006)
- Stein MA., "Unravelling sleep problems in treated and untreated children with ADHD", J Child Adolesc Psychopharmacol, 9, pp.157~168 (1999)
- Galland BC., "The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study", J Sleep Res, 19, pp.366~373 (2010)
- Ashkenasi A., "Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder", Pediatr Neurol, 45, pp.381~386 (2011)
- Kim HW., "The effect of OROS methylphenidate on the sleep of children with attention-deficit", hyperactivity disorder, 2010, pp.25, 107~115
- Anstead M., "Pediatric sleep disorders: new developments and evolving understanding", Curr Opin Pulm Med, 6, pp.501~506 (2000)
- Fallone G., "Effects of acute sleep restriction on behavior, sustained attention, and response inhibition in children", Percept Mot Skills, 93, pp.213~229 (2001)
- Stenuit P., "Effects of sleep restriction on cognition in women", Biol Psychol, 77, pp.81~88 (2008)
- van der Heijden KB., "Sleep-related disorders in ADHD: a review", Clin Pediatr (Phila), 44, pp.201~210 (2005)
- Kaufman J., "Schedule for Affective Disorders and Schizophrenia for School-Age Children- Present and Lifetime Version (K-SADS-PL): initial reliability and validity data", J Am Acad Child Adolesc Psychiatry, 36, pp.980~988 (1997)
- 김영신, "The Reliability and Validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean Version (K-SADS-PL-K)", Yonsei Medical Journal, 45(1), pp.81~89 (2004), 연세대학교의과대학
- Ng DK., "Prevalence of sleep problems in Hong Kong primary school children: a community-based telephone survey", Chest, 128, pp.1315~1323 (2005)
- Seo WS., "Sleep patterns and their age-related changes in elementary-school children", Sleep Med, 11, pp.569~575 (2010)
- Corkum P., "Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit", hyperactivity disorder, 2008, pp.33, 368~379
- Schwartz G., "Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo", J Am Acad Child Adolesc Psychiatry, 43, pp.1276~1282 (2004)
- Faraone SV., "Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD", J Atten Disord, 12, pp.308~315 (2009)
- Rochdi M., "Dose-proportional pharmacokinetics of a methylphenidate extended-release capsule", Int J Clin Pharmacol Ther, 42, pp.285~292 (2004)
- Modi NB., "Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation", J Clin Pharmacol, 40, pp.379~388 (2000)
- Pelham WE., "Once-a-day Concerta methylphenidate versus threetimes- daily methylphenidate in laboratory and natural settings", Pediatrics, 107, pp.105~ (2001)